Assessing small-sized D-fructose-functionalized micelles for active targeting of triple-negative breast cancer

ATR: Active Transport and Retention; CH2Cl2: Dichloromethane; CMC: Critical Micelle Concentration; DAPI: 4′,6-Diamidino-2-Phenylindole; DIC: N,N′-Diisopropylcarbodiimide; DLS: Dynamic Light Scattering; DMF: Dimethylformamide; DMSO: Dimethyl Sulfoxide; DXT: Docetaxel; EPR: Enhanced Permeability and R...

Descripción completa

Detalles Bibliográficos
Autores: Castillejos, M. Carmen, Zuliani, Alessio, Cova, Camilla M, Caro, Carlos, Noriega, Livia Lopez, Comaills, Valentine, García-Martín, María L., Gauthier, Benoit R., Khiar, Noureddine
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/397828
Acceso en línea:http://hdl.handle.net/10261/397828
https://api.elsevier.com/content/abstract/scopus_id/105011150976
Access Level:acceso abierto
Palabra clave:Triple-negative breast cancer
D-fructose
Drug delivery
Micelles
Nanomedicine
Descripción
Sumario:ATR: Active Transport and Retention; CH2Cl2: Dichloromethane; CMC: Critical Micelle Concentration; DAPI: 4′,6-Diamidino-2-Phenylindole; DIC: N,N′-Diisopropylcarbodiimide; DLS: Dynamic Light Scattering; DMF: Dimethylformamide; DMSO: Dimethyl Sulfoxide; DXT: Docetaxel; EPR: Enhanced Permeability and Retention; FACS: Fluorescence-Activated Cell Sorting; FRUC: D-fructose; GLUT5: Glucose Transporter type 5; H&E: Haematoxylin and Eosin; HPLC: High-Performance Liquid Chromatography; HRMS: High-Resolution Mass Spectrometry; IgG: Immunoglobulin G; NMR: Nuclear Magnetic Resonance; NR: Nile Red; PDA: Polydiacetylene; PCDA: Pentacosadiynoic Acid; PEG: Polyethylene Glycol; PBS: Phosphate Buffered Saline; ROI: Region of Interest; SD: Standard Deviation; TEM: Transmission Electron Microscopy; TFA: Trifluoroacetic Acid; THF: Tetrahydrofuran; TNBC: Triple-Negative Breast Cancer.